79 related articles for article (PubMed ID: 16863992)
1. Effect of the reduction of superoxide dismutase 1 and 2 or treatment with alpha-tocopherol on tumorigenesis in Atm-deficient mice.
Erker L; Schubert R; Elchuri S; Huang TT; Tarin D; Mueller K; Zielen S; Epstein CJ; Wynshaw-Boris A
Free Radic Biol Med; 2006 Aug; 41(4):590-600. PubMed ID: 16863992
[TBL] [Abstract][Full Text] [Related]
2. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.
Erker L; Schubert R; Yakushiji H; Barlow C; Larson D; Mitchell JB; Wynshaw-Boris A
Hum Mol Genet; 2005 Jun; 14(12):1699-708. PubMed ID: 15888486
[TBL] [Abstract][Full Text] [Related]
3. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.
Yoshida M; Shiojima I; Ikeda H; Komuro I
J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469
[TBL] [Abstract][Full Text] [Related]
4. Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.
Bhuller Y; Jeng W; Wells PG
Toxicol Sci; 2006 Sep; 93(1):146-55. PubMed ID: 16714389
[TBL] [Abstract][Full Text] [Related]
5. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice.
Kamsler A; Daily D; Hochman A; Stern N; Shiloh Y; Rotman G; Barzilai A
Cancer Res; 2001 Mar; 61(5):1849-54. PubMed ID: 11280737
[TBL] [Abstract][Full Text] [Related]
6. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice.
Reliene R; Fischer E; Schiestl RH
Cancer Res; 2004 Aug; 64(15):5148-53. PubMed ID: 15289318
[TBL] [Abstract][Full Text] [Related]
7. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice.
Schubert R; Erker L; Barlow C; Yakushiji H; Larson D; Russo A; Mitchell JB; Wynshaw-Boris A
Hum Mol Genet; 2004 Aug; 13(16):1793-802. PubMed ID: 15213104
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice.
Reliene R; Schiestl RH
DNA Repair (Amst); 2006 Jul; 5(7):852-9. PubMed ID: 16781197
[TBL] [Abstract][Full Text] [Related]
9. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
[TBL] [Abstract][Full Text] [Related]
10. A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture.
Bhuller Y; Wells PG
Toxicol Sci; 2006 Sep; 93(1):156-63. PubMed ID: 16790486
[TBL] [Abstract][Full Text] [Related]
11. Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis.
Rasheed N; Wang X; Niu QT; Yeh J; Li B
Hum Mol Genet; 2006 Jun; 15(12):1938-48. PubMed ID: 16644862
[TBL] [Abstract][Full Text] [Related]
12. Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant.
Gueven N; Luff J; Peng C; Hosokawa K; Bottle SE; Lavin MF
Free Radic Biol Med; 2006 Sep; 41(6):992-1000. PubMed ID: 16934683
[TBL] [Abstract][Full Text] [Related]
13. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
[TBL] [Abstract][Full Text] [Related]
14. Ataxia telangiectasia mutated (Atm) knockout mice as a model of osteopenia due to impaired bone formation.
Hishiya A; Ito M; Aburatani H; Motoyama N; Ikeda K; Watanabe K
Bone; 2005 Oct; 37(4):497-503. PubMed ID: 16027059
[TBL] [Abstract][Full Text] [Related]
15. Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress.
Shackelford RE; Manuszak RP; Johnson CD; Hellrung DJ; Link CJ; Wang S
DNA Repair (Amst); 2004 Oct; 3(10):1263-72. PubMed ID: 15336622
[TBL] [Abstract][Full Text] [Related]
16. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling.
Kim J; Wong PK
Stem Cells; 2009 Aug; 27(8):1987-98. PubMed ID: 19544430
[TBL] [Abstract][Full Text] [Related]
17. ATM is required for the cellular response to thymidine induced replication fork stress.
Bolderson E; Scorah J; Helleday T; Smythe C; Meuth M
Hum Mol Genet; 2004 Dec; 13(23):2937-45. PubMed ID: 15459181
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells.
Ambrose M; Goldstine JV; Gatti RA
Hum Mol Genet; 2007 Sep; 16(18):2154-64. PubMed ID: 17606465
[TBL] [Abstract][Full Text] [Related]
19. ATM controls c-Myc and DNA synthesis during postnatal thymocyte development through regulation of redox state.
Yan M; Zhu C; Liu N; Jiang Y; Scofield VL; Riggs PK; Qiang W; Lynn WS; Wong PK
Free Radic Biol Med; 2006 Aug; 41(4):640-8. PubMed ID: 16863997
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and functional characterization of zebrafish ATM.
Imamura S; Kishi S
Int J Biochem Cell Biol; 2005 May; 37(5):1105-16. PubMed ID: 15743681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
